Cargando…

Drug-resistant tuberculosis: is India ready for the challenge?

Detalles Bibliográficos
Autores principales:	Chatterjee, Soumya, Poonawala, Husain, Jain, Yogesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089296/ https://www.ncbi.nlm.nih.gov/pubmed/30116597 http://dx.doi.org/10.1136/bmjgh-2018-000971

Ejemplares similares

760. The Diversity of Mycobacterium tuberculosis in India Is Underestimated and Underreported
por: Poonawala, Husain, et al.
Publicado: (2018)

Controlling the drug-resistant tuberculosis epidemic in India: challenges and implications
por: Husain, Aliabbas A., et al.
Publicado: (2021)

Nuclear Medicine in India: Are We Pandemic Ready?
por: Puranik, Ameya D
Publicado: (2020)

Early detection of multi-drug resistant tuberculosis in India using GenoType MTBDRplus assay & profile of resistance mutations in Mycobacterium tuberculosis
por: Singh, Sarman
Publicado: (2014)

Are We Ready for NGS HIV Drug Resistance Testing? The Second “Winnipeg Consensus” Symposium
por: Ji, Hezhao, et al.
Publicado: (2020)

Commentary: Are we always ready for a challenging surprise?
por: Rackauskas, Mindaugas, et al.
Publicado: (2021)

Establishment of the African Medicines Agency: progress, challenges and regulatory readiness
por: Ncube, Bakani Mark, et al.
Publicado: (2021)

Extensively Drug-Resistant Mycobacterium tuberculosis, India
por: Mondal, Rajesh, et al.
Publicado: (2007)

Overcoming resistance to PARP inhibitor in epithelial ovarian cancer, are we ready?
por: Ray-Coquard, Isabelle, et al.
Publicado: (2020)

Prevalence and Therapeutic Challenges of Fungal Drug Resistance: Role for Plants in Drug Discovery
por: Marquez, Lewis, et al.
Publicado: (2020)

Consensus Statement on Research Definitions for Drug-Resistant Tuberculosis in Children
por: Seddon, James A., et al.
Publicado: (2013)

Commentary: The challenges of treating retinoblastoma in India
por: Shah, Parag K
Publicado: (2019)

NHS vs Modicare: The Indian Healthcare v2.0. Are we ready to build the healthier India that we envisage?
por: Nirula, Suvansh R., et al.
Publicado: (2019)

History, Structure and Agency in Global Health Governance: Comment on "Global Health Governance Challenges 2016 – Are We Ready?"
por: Gill, Stephen, et al.
Publicado: (2016)

The Shock Index: is it ready for primetime?
por: Moffat, Brad, et al.
Publicado: (2013)

Improving access to multi-drug resistant tuberculosis diagnostic and health services for refugees and migrants
por: Zumla, Alimuddin, et al.
Publicado: (2018)

Ringing the alarm bell: Time to scale up drug-resistant tuberculosis preventive treatment
por: Malik, Amyn A., et al.
Publicado: (2021)

Commentary: Diagnostic challenges in sarcoid uveitis in India
por: Biswas, Jyotirmay, et al.
Publicado: (2022)

Biogenerics: Are we ready to take safety challenges in India?
por: Budhiraja, Salil, et al.
Publicado: (2011)

Proteomics of multidrug resistant Mycobacterium tuberculosis clinical isolates: A peep show on mechanism of drug resistance & perhaps more
por: Parsa, Kishore, et al.
Publicado: (2015)

Only generics (drugs/names): Is India ready?
por: Dhamija, Puneet, et al.
Publicado: (2015)

Challenges in conducting a community-based influenza vaccine trial in a rural community in northern India
por: Kumar, Rakesh, et al.
Publicado: (2018)

Commentary: Almost ready for prime time
por: Wei, Lawrence M.
Publicado: (2020)

Will the DDS class of 2021 be practice ready?
por: Murdoch-Kinch, Carol Anne, et al.
Publicado: (2021)

Leprosy remains an important public health challenge in India
por: Richardus, Jan Hendrik
Publicado: (2013)

A New Gilded Age, and What It Means for Global Health: Comment on "Global Health Governance Challenges 2016 – Are We Ready?"
por: Schrecker, Ted
Publicado: (2016)

Molecular epidemiology of tuberculosis: Opportunities & challenges in disease control
por: Varma-Basil, Mandira, et al.
Publicado: (2017)

Linezolid-resistant Mycobacterium tuberculosis: Will it impact the tuberculosis elimination programme?
por: Bharadwaj, Renu
Publicado: (2021)

Geriatric population in India: Demography, vulnerabilities, and healthcare challenges
por: Malik, Chetanya, et al.
Publicado: (2021)

Minimum inhibitory concentration, pharmacokinetics/pharmacodynamics and therapeutic drug monitoring: An integrated approach for multidrug-resistant tuberculosis
por: Srivastava, Shashikant
Publicado: (2015)

The importance of physical examination in primary health care provided by NPHW is being threatened in COVID19 times
por: Jain, Rachna, et al.
Publicado: (2021)

Business as Usual: A Lack of Institutional Innovation in Global Health Governance: Comment on "Global Health Governance Challenges 2016 – Are We Ready?"
por: Lee, Kelley
Publicado: (2016)

Bacterial Identification using 16S rRNA Gene Sequencing in a University Teaching Hospital
por: Poonawala, Husain, et al.
Publicado: (2017)

The dire need for primary care specialization in India: Concerns and challenges
por: Faizi, Nafis, et al.
Publicado: (2016)

Deceased donor transplantation in India: How the challenges are being met?
por: Parthasarathy, R., et al.
Publicado: (2017)

End-of-Life Care and Opioid Use in India: Challenges and Opportunities
por: Jacob, Aasems, et al.
Publicado: (2017)

Doing more tests: Next challenge for Covid 19 in India
por: Roy, Manas Pratim
Publicado: (2020)

Commentary: Use of biosimilars for retinal diseases in India: Challenges and concerns
por: Kumar, Aman, et al.
Publicado: (2021)

Genetic counselling for hypertrophic cardiomyopathy: are we ready for it?
por: Vosberg, Hans-Peter
Publicado: (2000)

Is critical care ready for an economic surrogate endpoint?
por: Wilcox, M Elizabeth, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3uovf69h233amkl3lso8pt7chl